Last minute present before the Xmas 
European Commission Grants Intercept's Ocal... - PBC Foundation
European Commission Grants Intercept's Ocaliva® (obeticholic acid) Marketing Authorization
Written by
Betonarme
To view profiles and participate in discussions please or .
Read more about...
2 Replies
•
Thank you for this news.I have been waiting for this as my disease has progressed to cirrhosis despite taking urso.I can ask my consultant now next time I see him.
Jane
That is fantastic news! Hopefully the rest of the world not too far behind
Not what you're looking for?
You may also like...
FDA Grants Priority Review for Intercept's Obeticholic Acid for the Treatment of Primary Biliary Cirrhosis. See link below
ir.interceptpharma.com/releasedetail.cfm?ReleaseID=929359
FDA Drug Safety Communication: FDA warns about serious liver injury with Ocaliva (obeticholic acid) for rare chronic liver disease
It sounds alarmist, it seems mainly to be incorrect dosage given and as a patient being considered...
